Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans

por Gonzales, Jon C., Gordts, Philip L.S.M., Foley, Erin M., Esko, Jeffrey D.
Publicado 2013

Shedding of syndecan-1 from human hepatocytes alters VLDL clearance

por Deng, Yiping, Foley, Erin M., Gonzales, Jon C., Gordts, Philip L., Li, Yulin, Esko, Jeffrey D.
Publicado 2011

Hepatic Remnant Lipoprotein Clearance by Heparan Sulfate Proteoglycans and Low-Density Lipoprotein Receptors Depend on Dietary Conditions in Mice

por Foley, Erin M., Gordts, Philip L.S.M., Stanford, Kristin I., Gonzales, Jon C., Lawrence, Roger, Stoddard, Nicole, Esko, Jeffrey D.
Publicado 2013

Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice

por Stanford, Kristin I., Bishop, Joseph R., Foley, Erin M., Gonzales, Jon C., Niesman, Ingrid R., Witztum, Joseph L., Esko, Jeffrey D.
Publicado 2009

Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease

por Gentile, Christopher L., Nivala, Angela M., Gonzales, Jon C., Pfaffenbach, Kyle T., Wang, Dong, Wei, Yuren, Jiang, Hua, Orlicky, David J., Petersen, Dennis R., Pagliassotti, Michael J., Maclean, Kenneth N.
Publicado 2011

Deletion of the Basement Membrane Heparan Sulfate Proteoglycan Type XVIII Collagen Causes Hypertriglyceridemia in Mice and Humans

por Bishop, Joseph R., Passos-Bueno, Maria Rita, Fong, Loren, Stanford, Kristin I., Gonzales, Jon C., Yeh, Erika, Young, Stephen G., Bensadoun, Andre, Witztum, Joseph L., Esko, Jeffrey D., Moulton, Karen S.
Publicado 2010

ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors

por Gordts, Philip L.S.M., Nock, Ryan, Son, Ni-Huiping, Ramms, Bastian, Lew, Irene, Gonzales, Jon C., Thacker, Bryan E., Basu, Debapriya, Lee, Richard G., Mullick, Adam E., Graham, Mark J., Goldberg, Ira J., Crooke, Rosanne M., Witztum, Joseph L., Esko, Jeffrey D.
Publicado en J Clin Invest (2016)